BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 26772409)

  • 1. Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health.
    Joyce SA; Gahan CG
    Annu Rev Food Sci Technol; 2016; 7():313-33. PubMed ID: 26772409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between gut bacteria and bile in health and disease.
    Long SL; Gahan CGM; Joyce SA
    Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between bile acids and intestinal microbiota in host metabolism and health.
    Nie YF; Hu J; Yan XH
    J Zhejiang Univ Sci B; 2015 Jun; 16(6):436-46. PubMed ID: 26055905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
    Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
    BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota.
    Joyce SA; Gahan CG
    Dig Dis; 2017; 35(3):169-177. PubMed ID: 28249284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation.
    Zhang L; Nichols RG; Correll J; Murray IA; Tanaka N; Smith PB; Hubbard TD; Sebastian A; Albert I; Hatzakis E; Gonzalez FJ; Perdew GH; Patterson AD
    Environ Health Perspect; 2015 Jul; 123(7):679-88. PubMed ID: 25768209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.
    Jia W; Xie G; Jia W
    Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):111-128. PubMed ID: 29018272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bile acids in metabolic regulation.
    Vítek L; Haluzík M
    J Endocrinol; 2016 Mar; 228(3):R85-96. PubMed ID: 26733603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids as metabolic regulators.
    Li T; Chiang JY
    Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.
    Degirolamo C; Rainaldi S; Bovenga F; Murzilli S; Moschetta A
    Cell Rep; 2014 Apr; 7(1):12-8. PubMed ID: 24656817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile Acid Metabolism in Liver Pathobiology.
    Chiang JYL; Ferrell JM
    Gene Expr; 2018 May; 18(2):71-87. PubMed ID: 29325602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases.
    Jia ET; Liu ZY; Pan M; Lu JF; Ge QY
    J Zhejiang Univ Sci B; 2019 Oct.; 20(10):781-792. PubMed ID: 31489798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.
    Fiorucci S; Distrutti E
    Trends Mol Med; 2015 Nov; 21(11):702-714. PubMed ID: 26481828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions.
    Chi L; YifeiYang ; Bian X; Gao B; Tu P; Ru H; Lu K
    Sci Total Environ; 2024 Apr; 919():169603. PubMed ID: 38272087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
    Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Bäckhed F; Marschall HU
    Dig Dis; 2017; 35(3):246-250. PubMed ID: 28249261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.
    Klaassen CD; Cui JY
    Drug Metab Dispos; 2015 Oct; 43(10):1505-21. PubMed ID: 26261286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
    Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
    Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.